GO:0086075 gap junction channel activity involved in cardiac conduction electrical coupling: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086075 describes a wide-pore channel activity that creates a direct cytoplasmic connection between adjacent cardiomyocytes, allowing electrical signals to pass and contributing to cardiac conduction.
• Connexin proteins, especially GJA1 (connexin43), form the gap junction channels responsible for this activity in the heart.
• Gap junction channels permit rapid passage of ions and small molecules, enabling synchronized contraction of cardiac muscle.
• Altered gap junction function is linked to arrhythmias such as atrial fibrillation and to cardiac fibroblast-cardiomyocyte coupling.
• Computational and experimental models show that gap junction distribution and perinexal sodium channel clustering modulate impulse transmission.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal role of connexins and associated proteins in cardiac conduction.
Description
GO:0086075, gap junction channel activity involved in cardiac conduction electrical coupling, is a molecular function term that defines the activity of gap junction channels specifically in the context of electrical coupling between cardiomyocytes. This activity enables a direct cytoplasmic connection from one cardiomyocyte to an adjacent cardiomyocyte, allowing the passage of electrical signals that contribute to cardiac conduction. Gap junctions are composed of connexin proteins, and in the heart, connexin43 (GJA1) is the predominant isoform responsible for this electrical coupling. The importance of this term lies in its central role in cardiac physiology: coordinated contraction of the heart depends on rapid, synchronized electrical activation of cardiomyocytes, which is mediated by gap junction channels. Dysregulation of gap junction channel activity has been implicated in arrhythmogenesis, including atrial fibrillation and other conduction disorders. Researchers studying cardiac electrophysiology, developmental biology, and disease modeling require a precise understanding of this GO term to design experiments and interpret data on intercellular communication.
gap junction channel activity involved in cardiac conduction electrical coupling At A Glance
| GO ID | GO:0086075 |
|---|---|
| GO term | gap junction channel activity involved in cardiac conduction electrical coupling |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Enables direct cytoplasmic connection between adjacent cardiomyocytes for electrical signal passage. |
| Cellular location | Gap junctions at the intercalated discs of cardiomyocytes. |
| Key proteins | Connexins, primarily GJA1 (connexin43), and associated scaffolding proteins. |
| Physiological role | Synchronizes cardiac action potential propagation and contraction. |
| Disease relevance | Arrhythmias, atrial fibrillation, and cardiac fibroblast-cardiomyocyte coupling. |
What Is GO:0086075?
According to the Gene Ontology, GO:0086075 is a molecular function defined as a wide pore channel activity that enables a direct cytoplasmic connection from one cardiomyocyte to an adjacent cardiomyocyte. The gap junction passes electrical signals between the cells contributing to cardiac conduction. In simpler terms, it is the activity of gap junction channels that electrically couples heart muscle cells, allowing them to communicate directly and synchronize their contractions.
Why Is gap junction channel activity involved in cardiac conduction electrical coupling Important in Cell Biology?
GO:0086075 is critically important because it defines the molecular activity that underlies electrical coupling in the heart. Without functional gap junction channels, cardiac action potentials cannot propagate efficiently from cell to cell, leading to conduction slowing or block, which can be lethal. This term is also essential for understanding how non-excitable cells such as cardiac fibroblasts can electrically couple with cardiomyocytes and influence arrhythmogenesis. Moreover, gap junction channel activity is dynamically regulated by adrenergic signaling and pathological remodeling, making it a target for therapeutic interventions in atrial fibrillation and heart failure.
• Enables rapid electrical impulse propagation through the heart, essential for coordinated contraction.
• Maintains normal cardiac rhythm; dysfunction leads to arrhythmias including atrial fibrillation.
• Facilitates metabolic and electrical coupling between cardiomyocytes and fibroblasts.
• Target of adrenergic regulation, linking stress responses to conduction changes.
• Involved in developmental patterning of the heart and maturation of conduction system.
• Provides a model for studying intercellular communication in excitable tissues.
• Key to understanding ephaptic coupling and sodium channel clustering at gap junctions.
• Potential therapeutic target for restoring conduction in diseased myocardium.
• Used in computational models to predict conduction velocity and arrhythmia risk.
• Relevant to tissue engineering and regenerative medicine for creating functional cardiac grafts.
What Happens During gap junction channel activity involved in cardiac conduction electrical coupling?
Channel Formation and Docking
In simple terms: Two heart muscle cells build tiny tunnels that connect their insides.
Gap junction channels are formed by connexin proteins, which assemble into hexameric hemichannels (connexons) in the plasma membrane. In cardiomyocytes, connexin43 (GJA1) is the major isoform. A hemichannel from one cell docks with a matching hemichannel from an adjacent cell to form a complete gap junction channel, creating a continuous aqueous pore between the cytoplasms. This docking is essential for the direct cytoplasmic connection described in GO:0086075.
Electrical Signal Transmission
In simple terms: Ions flow directly from one cell to the next, carrying the electrical signal.
Once formed, gap junction channels allow the passive diffusion of ions, including sodium, potassium, and calcium, down their electrochemical gradients. This ion flow carries the cardiac action potential from one cardiomyocyte to the next, enabling electrical coupling and contributing to cardiac conduction. The wide pore of the channel permits rapid transmission, ensuring synchronized depolarization of the myocardium.
Regulation by Phosphorylation and Adrenergic Signaling
In simple terms: Chemical tags and stress hormones can open or close these tunnels.
Gap junction channel activity is dynamically regulated. Phosphorylation of connexin43 by kinases such as protein kinase A and protein kinase C modulates channel open probability and turnover. Adrenergic stimulation, via beta-adrenergic receptors, can acutely increase gap junction conductance and alter expression levels, thereby tuning conduction velocity to physiological demand. This regulation is critical for adapting cardiac conduction during exercise or stress.
Interaction with Other Membrane Proteins
In simple terms: The tunnels work together with other proteins to fine-tune the signal.
Gap junctions are not isolated; they interact with voltage-gated sodium channels (e.g., SCN5A) and scaffolding proteins. Recent models suggest that sodium channel clusters in the perinexal region of gap junctions enhance impulse transmission via ephaptic coupling, a mechanism where local electric fields modulate excitability. This interplay ensures robust conduction even under conditions of reduced gap junction coupling.
Remodeling in Disease
In simple terms: In heart disease, these tunnels can change in number or location, disrupting the signal.
Pathological conditions such as atrial fibrillation and heart failure are associated with altered expression, distribution, and phosphorylation of connexin43, leading to impaired electrical coupling. For example, conductive polymer treatment has been shown to restore connexin43 expression and improve intercellular communication in atrial fibrillation models. Cardiac fibroblasts can also form gap junctions with cardiomyocytes, contributing to arrhythmogenic substrate.
Key Genes Involved in GO:0086075 gap junction channel activity involved in cardiac conduction electrical coupling
The following genes encode proteins that are directly involved in gap junction channel activity involved in cardiac conduction electrical coupling, including connexins, scaffolding proteins, and ion channels that modulate this function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GJA1 | Forms connexin43 gap junction channels; primary mediator of cardiac electrical coupling | Most studied connexin in heart; knockout lethal; key target for arrhythmia research |
| GJA5 | Forms connexin40 channels; expressed in atrial and conduction system | Implicated in atrial fibrillation; potential modifier of conduction velocity |
| GJC1 | Forms connexin45 channels; expressed in conduction system and ventricles | Modulates gap junction heterogeneity; knockout leads to conduction defects |
| GJA3 | Forms connexin46 channels; less abundant in heart | May contribute to specialized conduction; understudied |
| GJB1 | Forms connexin32 channels; found in some cardiac tissues | Potential role in developmental conduction; not well characterized |
| GJB2 | Forms connexin26 channels; expressed in heart | May modulate gap junctional communication; linked to deafness but cardiac role unclear |
| SCN5A | Voltage-gated sodium channel; clusters near gap junctions | Modulates ephaptic coupling; mutations cause Brugada syndrome and conduction disease |
| PKP2 | Desmosomal protein; interacts with connexin43 | Mutations cause arrhythmogenic cardiomyopathy; affects gap junction remodeling |
| DSP | Desmoplakin; links desmosomes to gap junctions | Arrhythmogenic right ventricular cardiomyopathy; gap junction disruption |
| CTNNB1 | Beta-catenin; adherens junction protein | Links cell adhesion to gap junction function; role in cardiac remodeling |
| TJP1 | Zonula occludens-1; scaffolds connexin43 | Regulates gap junction size and turnover; knockout affects conduction |
| PRKACA | Catalytic subunit of PKA; phosphorylates connexin43 | Adrenergic regulation of gap junctions; modulates channel activity |
| PRKCA | Protein kinase C alpha; phosphorylates connexin43 | Regulates gap junction gating and remodeling in disease |
| MAPK1 | ERK2; phosphorylates connexin43 | Involved in MAPK-mediated downregulation of connexin43 in atrial fibrillation |
| MAPK3 | ERK1; phosphorylates connexin43 | Contributes to gap junction remodeling; target for therapeutic intervention |
| ADRB1 | Beta-1 adrenergic receptor; mediates catecholamine effects | Regulates gap junction conductance and expression |
| ADRB2 | Beta-2 adrenergic receptor; mediates catecholamine effects | Modulates gap junction function in stress responses |
| KCNJ2 | Inward rectifier potassium channel; affects resting potential | Mutations cause Andersen-Tawil syndrome; may influence gap junction coupling |
How Is gap junction channel activity involved in cardiac conduction electrical coupling Regulated?
Gap junction channel activity involved in cardiac conduction electrical coupling is regulated at multiple levels. Acute regulation occurs via phosphorylation of connexin43 by protein kinases such as PKA and PKC, which can alter channel open probability and conductance. Adrenergic signaling through beta-adrenergic receptors modulates both the activity and expression of gap junction proteins, adapting conduction to physiological demands. Chronic regulation involves changes in connexin43 gene expression, trafficking, and degradation, often mediated by MAPK signaling pathways; for instance, suppression of MAPKs restores connexin43 expression and improves intercellular communication in atrial fibrillation models. Additionally, interactions with scaffolding proteins like TJP1 and adherens junction components influence gap junction assembly and stability.
gap junction channel activity involved in cardiac conduction electrical coupling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GJA1 | Atrial fibrillation, heart failure, arrhythmias | Cardiomyocyte-specific knockout; point mutations in phosphorylation sites; overexpression |
| GJA5 | Atrial fibrillation, conduction disease | Knockout mice; knock-in of human mutations; atrial-specific overexpression |
| SCN5A | Brugada syndrome, conduction slowing | Knock-in of SCN5A mutations; co-culture with gap junction modulators |
| PKP2 | Arrhythmogenic right ventricular cardiomyopathy | Knockout or point mutation in iPSC-derived cardiomyocytes; rescue with connexin43 overexpression |
| MAPK1/MAPK3 | Atrial fibrillation, gap junction remodeling | Knockout or pharmacological inhibition; overexpression of constitutively active mutants |
Atrial Fibrillation and Conduction Disorders
Atrial fibrillation is the most common sustained arrhythmia and is strongly associated with gap junction remodeling. Reduced expression and lateralization of connexin43 impair electrical coupling, contributing to reentrant circuits. A conductive polymer has been shown to restore connexin43 expression through suppression of MAPKs, improving intercellular communication and alleviating atrial fibrillation in experimental models. Similarly, mutations in GJA5 (connexin40) have been linked to atrial fibrillation susceptibility.
Cardiac Fibrosis and Fibroblast-Cardiomyocyte Coupling
Cardiac fibroblasts are active players in atrial electrophysiology. Under pathological conditions, fibroblasts can form gap junctions with cardiomyocytes, altering conduction properties and promoting arrhythmogenesis. This heterotypic coupling involves connexin43 and possibly connexin45, and can be modulated by BK(Ca) channel activity in human cardiac fibroblasts. Targeting fibroblast-cardiomyocyte coupling is a potential therapeutic strategy for fibrosis-related arrhythmias.
Arrhythmogenic Cardiomyopathy and Desmosomal Mutations
Mutations in desmosomal genes such as PKP2 and DSP cause arrhythmogenic cardiomyopathy, characterized by fibrofatty replacement and conduction defects. These mutations disrupt gap junction function indirectly by impairing cell adhesion and cytoskeletal integrity, leading to reduced connexin43 at intercalated discs. This highlights the interdependence of desmosomes and gap junctions in maintaining cardiac electrical stability.
Heart Failure and Ischemic Injury
In heart failure and after myocardial infarction, gap junction distribution becomes heterogeneous, slowing conduction and increasing arrhythmia risk. Adrenergic overstimulation and altered kinase signaling contribute to connexin43 dephosphorylation and degradation. Computational models incorporating gap junction properties help predict conduction changes and guide therapeutic approaches.
From gap junction channel activity involved in cardiac conduction electrical coupling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GJA1 abolish cardiac electrical coupling? | Cardiomyocyte-specific GJA1 knockout mouse or human iPSC-derived cardiomyocytes with CRISPR knockout |
| How do phosphorylation site mutations in connexin43 affect channel gating? | Point-mutation knock-in of phospho-deficient or phospho-mimetic GJA1 in cardiomyocytes |
| Can a disease-associated GJA5 mutation recapitulate atrial fibrillation? | Knock-in mouse model expressing mutant GJA5 or iPSC-derived atrial cardiomyocytes |
| What is the effect of connexin43 overexpression on conduction velocity? | Adenoviral or lentiviral overexpression of GJA1 in cardiomyocyte monolayers or in vivo |
| How does fibroblast-cardiomyocyte coupling modulate arrhythmogenesis? | Co-culture of cardiac fibroblasts and cardiomyocytes with connexin knockout or overexpression |
| Does ephaptic coupling at gap junctions enhance impulse transmission? | Computational model with sodium channel clustering and gap junction distribution; validated by SCN5A knock-in |
How to Study the gap junction channel activity involved in cardiac conduction electrical coupling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Dual patch-clamp | Gap junction conductance and gating | Assess connexin channel function in isolated cell pairs |
| Optical mapping | Conduction velocity and action potential propagation | Evaluate arrhythmia risk in cardiac tissue |
| Immunofluorescence | Connexin43 localization and expression | Detect gap junction remodeling in disease models |
| Western blot | Connexin43 protein levels and phosphorylation status | Quantify changes after adrenergic stimulation or MAPK inhibition |
| Computational simulation | Predicted conduction velocity and ephaptic effects | Integrate experimental data to understand mechanisms |
| Co-culture assays | Heterotypic coupling between fibroblasts and cardiomyocytes | Study arrhythmogenic role of fibroblasts |
| CRISPR screening | Identify genes modulating gap junction function | Discover novel regulators of electrical coupling |
| RNA-seq | Transcriptional changes in connexins and related genes | Profile gap junction remodeling in heart disease |
Electrophysiological Assays
Patch-clamp and dual-cell voltage-clamp techniques directly measure gap junction channel conductance and gating properties. These methods are used to assess the functional impact of connexin mutations or regulatory changes on electrical coupling between cardiomyocytes.
Optical Mapping and Calcium Imaging
Optical mapping with voltage-sensitive dyes or calcium indicators visualizes action potential propagation in cardiac tissue or cardiomyocyte monolayers. This allows quantification of conduction velocity and arrhythmia inducibility in response to gap junction modulation.
Immunofluorescence and Confocal Microscopy
Localization and quantification of connexin43 at intercalated discs can be assessed by immunofluorescence. This method reveals changes in gap junction distribution, such as lateralization, in disease models or after genetic manipulation.
Computational Modeling
Cell-based computational models integrate gap junction conductance, sodium channel kinetics, and tissue geometry to simulate cardiac conduction. These models help predict the effects of gap junction remodeling and ephaptic coupling on impulse transmission.
How CRISPR Can Be Used to Study GO:0086075 gap junction channel activity involved in cardiac conduction electrical coupling
Knockout
CRISPR knockout of GJA1 in cardiomyocytes or animal models abolishes connexin43 expression, leading to loss of electrical coupling and severe conduction defects. Knockout models are used to establish the essential role of gap junction channels in cardiac conduction and to study compensatory mechanisms.
Point Mutation
Point mutations in GJA1 or GJA5 can mimic human disease variants that alter channel gating, phosphorylation, or trafficking. CRISPR-mediated knock-in of these mutations in iPSC-derived cardiomyocytes allows precise dissection of molecular mechanisms underlying conduction disorders.
Knock-in
Knock-in of reporter tags (e.g., GFP) into the GJA1 locus enables live-cell imaging of connexin43 dynamics and gap junction turnover. This approach is valuable for tracking channel assembly and degradation in response to stress or drugs.
Overexpression
CRISPR activation (CRISPRa) or viral overexpression of GJA1 increases connexin43 levels, which can enhance conduction velocity and rescue coupling defects in disease models. Overexpression studies help determine whether restoring gap junction function is therapeutic.
How EDITGENE Supports gap junction channel activity involved in cardiac conduction electrical coupling Research
Researchers studying gap junction channel activity involved in cardiac conduction electrical coupling-related genes often need to determine whether a candidate gene is causally involved in electrical coupling, arrhythmia susceptibility, or cardiac development. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling functional validation of connexins and associated proteins.
Contact EDITGENE today to design your custom CRISPR model for gap junction channel activity involved in cardiac conduction electrical coupling research.
Frequently Asked Questions About gap junction channel activity involved in cardiac conduction electrical coupling
What is GO:0086075?
GO:0086075 is a Gene Ontology molecular function term describing gap junction channel activity that enables direct cytoplasmic connection between adjacent cardiomyocytes, allowing electrical signal passage for cardiac conduction.
What genes are involved in gap junction channel activity involved in cardiac conduction electrical coupling?
Key genes include GJA1 (connexin43), GJA5 (connexin40), GJC1 (connexin45), and modulators such as SCN5A, PKP2, and MAPK1/3.
How does gap junction channel activity contribute to cardiac conduction?
It allows ions to flow directly between cardiomyocytes, propagating the action potential and synchronizing contraction.
What diseases are associated with defects in gap junction channel activity?
Atrial fibrillation, heart failure, arrhythmogenic cardiomyopathy, and conduction disorders are linked to gap junction remodeling.
Which connexin is most important for cardiac electrical coupling?
Connexin43, encoded by GJA1, is the predominant connexin in ventricular myocardium and is critical for electrical coupling.
How is gap junction channel activity regulated?
It is regulated by phosphorylation via PKA, PKC, and MAPKs, as well as by adrenergic signaling and protein trafficking.
Can CRISPR be used to study gap junction channel activity?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect the role of connexins in cardiac conduction.
What methods measure gap junction channel activity?
Dual patch-clamp, optical mapping, immunofluorescence, and computational modeling are common methods.
What is the role of cardiac fibroblasts in gap junction coupling?
Cardiac fibroblasts can form gap junctions with cardiomyocytes, influencing conduction and arrhythmogenesis.
How does ephaptic coupling relate to gap junctions?
Ephaptic coupling involves electric field effects from sodium channel clusters near gap junctions, enhancing impulse transmission when gap junction coupling is reduced.
Conclusion
GO:0086075, gap junction channel activity involved in cardiac conduction electrical coupling, is a fundamental molecular function that ensures rapid and synchronized electrical activation of the heart. Its core components, the connexins, are regulated by phosphorylation and adrenergic signaling, and their dysfunction is implicated in prevalent arrhythmias such as atrial fibrillation. Understanding this term is essential for cardiac researchers, and CRISPR-based models offer powerful tools to dissect its mechanisms and identify therapeutic targets.
References
- 1. Nielsen MS et al.. 2012. Gap junctions.. Compr Physiol 2(3):1981-2035 PMID: 23723031
- 2. Klesen A et al.. 2018. Cardiac fibroblasts : Active players in (atrial) electrophysiology?. Herzschrittmacherther Elektrophysiol 29(1):62-69 PMID: 29392412
- 3. Rohr S. 2004. Role of gap junctions in the propagation of the cardiac action potential.. Cardiovasc Res 62(2):309-22 PMID: 15094351
- 4. Wang YJ et al.. 2006. Contribution of BK(Ca)-channel activity in human cardiac fibroblasts to electrical coupling of cardiomyocytes-fibroblasts.. J Membr Biol 213(3):175-85 PMID: 17483867
- 5. Salameh A et al.. 2011. Adrenergic control of cardiac gap junction function and expression.. Naunyn Schmiedebergs Arch Pharmacol 383(4):331-46 PMID: 21318337
- 6. Zhang CY et al.. 2025. A conductive polymer restores connexin43 expression through the suppression of mitogen-activated protein kinases to improve intercellular communication and alleviate atrial fibrillation.. Acta Biomater 196:123-135 PMID: 40023467
- 7. Jæger KH et al.. 2019. Properties of cardiac conduction in a cell-based computational model.. PLoS Comput Biol 15(5):e1007042 PMID: 31150383
- 8. Ivanovic E et al.. 2021. Localization of Na(+) channel clusters in narrowed perinexi of gap junctions enhances cardiac impulse transmission via ephaptic coupling: a model study.. J Physiol 599(21):4779-4811 PMID: 34533834
